← Back to Clinical Trials
Recruiting NCT07287280

NCT07287280 Comparing CCI and POSSUM for Predicting Oncogynecologic Surgery Complications

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07287280
Status Recruiting
Phase
Sponsor Mahidol University
Condition Gynecologic Surgical Procedures
Study Type OBSERVATIONAL
Enrollment 300 participants
Start Date 2025-09-01
Primary Completion 2027-06-30

Trial Parameters

Condition Gynecologic Surgical Procedures
Sponsor Mahidol University
Study Type OBSERVATIONAL
Phase N/A
Enrollment 300
Sex FEMALE
Min Age 18 Years
Max Age N/A
Start Date 2025-09-01
Completion 2027-06-30
Interventions
CCI scorePOSSUM score

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

With the global rates of gynecologic cancers on the rise, optimizing perioperative care is imperative. Accurate risk prediction is essential for enhancing patient care, directing preoperative interventions, and facilitating informed decision-making in oncology. This research compares two widely-used risk assessment tools: the Charlson Comorbidity Index (CCI) and the Physiological and Operative Severity Score for the enUmeration of Mortality and Morbidity (POSSUM), in predicting perioperative outcomes. The CCI predominantly addresses comorbidities, providing simplicity and broad applicability, while POSSUM incorporates both physiological and operative factors for a more comprehensive risk assessment. Despite their application across various surgical specialties, the specific utility of these tools in onco-gynecologic surgery remains insufficiently explored. The study aims to evaluate the effectiveness of CCI and POSSUM in predicting perioperative complications, with a focus on the incidence of these complications, length of hospital stay, and 30-day mortality. The implementation of these risk tools may enhance multidisciplinary risk management, thus improving patient outcomes in gynecologic oncology surgery.

Eligibility Criteria

Inclusion Criteria: * Age \> 18 years * Patient underwent elective onco-gynecologic surgery Exclusion Criteria: * Patient required emergency surgery from any indication * Patient chart that not contained primary outcome data eg. absent of the anesthetic record

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology